Read articles from Global

November 18, 2025 by worldvapersalliance.com

COP11 Day 1: The Echo Chamber Effect

COP11 opened with familiar praises for stringent restrictions on nicotine products, neglecting actual evidence. The World Health Organization's decisions at COP11 lack transparency and focus excessively on bans rather than effective measures. Embracing harm reduction over prohibition has significantly lowered smoking rates in some countries. While many nations advocate for harsh restrictions, New Zealand and Serbia stand out by advocating harm reduction and evidence-based policies. These voices challenge the prevailing narrative and emphasize the importance of data-driven decision-making. Despite existing success stories, the influence of donors aligned with prohibition continues to dominate the conversation at COP11, limiting progress towards more effective solutions.

November 18, 2025 by regulatorwatch.com

GOOD COP 2.0 | Day 2 of 5 | RegWatch (Live)

DAY #2 | Live from Geneva, Switzerland – RegWatch special coverage of the Taxpayers Protection Alliance’s Good COP 2.0, the tobacco harm reduction counter-conference to the World Health Organization’s COP 11.

November 18, 2025 by regulatorwatch.com

GOOD COP 2.0 | Day 2 of 5 | RegWatch (Live)

DAY #2 | Live from Geneva, Switzerland – RegWatch special coverage of the Taxpayers Protection Alliance’s Good COP 2.0, the tobacco harm reduction counter-conference to the World Health Organization’s COP 11.

November 17, 2025 by manilatimes.net

Ex-WHO officials call for global tobacco control reset to save millions

Former WHO officials have called on governments to revamp global tobacco control strategies, warning that ignoring tobacco harm reduction (THR) could cost millions of lives. In a new report, Tikki Pang, Derek Yach, Chris Snowdon, and Peter Beckett argued that the Framework Convention on Tobacco Control (FCTC) needs a “reset” to include safer nicotine products like e-cigarettes, heated tobacco devices, and oral nicotine pouches. They emphasized that broader access to these lower-risk alternatives could sharply reduce smoking-related deaths, especially in low- and middle-income countries with high cigarette consumption.

November 17, 2025 by regulatorwatch.com

It's excellent, thank you. I'm sharing this on NSP

Live from Geneva, Switzerland – RegWatch brings you exclusive coverage of the Taxpayers Protection Alliance’s Good COP 2.0, a tobacco harm reduction counter-conference held alongside the WHO’s COP 11. Good COP 2.0 gathers 37 experts from 22 countries to distinguish facts from myths and challenge the misinformation influencing global health policy.

November 17, 2025 by regulatorwatch.com

GOOD COP 2.0 | Day 1 of 5 | RegWatch (Live)

Live from Geneva, Switzerland – RegWatch brings you exclusive coverage of the Taxpayers Protection Alliance’s Good COP 2.0, a tobacco harm reduction counter-conference held alongside the WHO’s COP 11. Good COP 2.0 gathers 37 experts from 22 countries to distinguish facts from myths and challenge the misinformation influencing global health policy.

November 14, 2025 by substack.com

WHO position on harm reduction : enough is enough

The WHO recently released a paper on tobacco control and harm reduction before the FCTC COP-11. It discusses harm reduction in tobacco and nicotine products, refuting claims that non-combustible products are as harmful as cigarettes and criticizing the WHO's stance on harm reduction as aligned with the tobacco industry. The document calls for prohibition and restrictive measures against these products, ignoring their potential role in reducing harm from smoking. These recommendations may inadvertently protect the cigarette market, contradicting the WHO's objectives. It emphasizes the need for a balanced approach to tobacco control.

November 14, 2025 by regulatorwatch.com

Hostile WHO | Exclusionary Tactics Threaten Tobacco Harm Reduction | RegWatch

As the WHO’s Framework Convention on Tobacco Control (FCTC) prepares for COP11 in Geneva, its track record of silencing dissent and bending evidence to demonize safer nicotine products stands exposed. Through tortured data, selective science, and an absolutist anti-nicotine agenda bankrolled by billionaire donors, the FCTC has shifted from a treaty against smoking to a template for exclusionary global health governance—one that ignores evidence, excludes dissenting experts, and punishes nations that embrace harm reduction. Joining RegWatch to dissect this threat is Dr. Roger Bate, PhD economist, international health policy researcher, and nonresident scholar at the International Center for Law and Economics. Dr. Bate explains how WHO’s hostility to market-driven alternatives isn’t just misguided—it’s dangerous.

November 14, 2025 by regulatorwatch.com

Hostile WHO | Exclusionary Tactics Threaten Tobacco Harm Reduction | RegWatch

As the WHO’s Framework Convention on Tobacco Control (FCTC) prepares for COP11 in Geneva, its track record of silencing dissent and bending evidence to demonize safer nicotine products stands exposed. Through tortured data, selective science, and an absolutist anti-nicotine agenda bankrolled by billionaire donors, the FCTC has shifted from a treaty against smoking to a template for exclusionary global health governance—one that ignores evidence, excludes dissenting experts, and punishes nations that embrace harm reduction. Joining RegWatch to dissect this threat is Dr. Roger Bate, PhD economist, international health policy researcher, and nonresident scholar at the International Center for Law and Economics. Dr. Bate explains how WHO’s hostility to market-driven alternatives isn’t just misguided—it’s dangerous.

November 14, 2025 by regulatorwatch.com

Hostile WHO | Exclusionary Tactics Threaten Tobacco Harm Reduction | RegWatch

As the WHO’s Framework Convention on Tobacco Control (FCTC) prepares for COP11 in Geneva, its track record of silencing dissent and bending evidence to demonize safer nicotine products stands exposed. Through tortured data, selective science, and an absolutist anti-nicotine agenda bankrolled by billionaire donors, the FCTC has shifted from a treaty against smoking to a template for exclusionary global health governance—one that ignores evidence, excludes dissenting experts, and punishes nations that embrace harm reduction. Joining RegWatch to dissect this threat is Dr. Roger Bate, PhD economist, international health policy researcher, and nonresident scholar at the International Center for Law and Economics. Dr. Bate explains how WHO’s hostility to market-driven alternatives isn’t just misguided—it’s dangerous.